Finite-Lived Intangible Asset, Expected Amortization, Year Four

Name: Collegium Pharmaceutical, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Four by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Collegium Pharmaceutical, Inc.·Products & Services·5 segments·Rolls up to Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)

Breakdown

Segment	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Jornay PM	—	$83.83M	$83.83M	$83.83M	$83.83M	$83.83M	$83.83M	$83.83M
Symproic	$7.29M	$7.29M	$7.29M	$7.29M	$7.29M	$7.29M	—	$7.29M
Belbuca	—	—	—	—	—	—	$0	$0
Symproic and other	—	—	—	—	—	—	$7.29M	—
Total	—	—	—	—	—	—	—	$91.11M

Segments

BelbucaView metric

Jornay PMView metric

Nucynta ProductsView metric

Symproic and otherView metric

SymproicView metric